
| Revenue | $10 - $100 million See Exact Annual Revenue |
|---|---|
| Employees | 10 - 100Exact Company Size |
| Primary Industry | 325411 Medicinal & Botanical Manufacturing |
| Additional NAICS Codes | 325412 Pharmaceutical Preparation Manufacturing 44611 Pharmacies & Drug Stores |
| Address | 777 Taylor St Ste 1050 Fort Worth, TX 76102 |
| Eyevance Pharmaceuticals | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
|---|---|---|---|
| 2025 | $10 - $100 million Details in Premium Report | ||
| 2024 | |||
| 2023 | |||
| 2021 | |||
| 2020 | |||
| 2019 | |||
|
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
| Eyevance Pharmaceuticals P&L | $ Millions |
|---|---|
| Revenue (Sales) | ![]() |
| Cost of Goods Sold | |
| Gross Profit | |
Operating Expenses | |
| Advertising | |
| Salaries and wages | |
| Other Operating Expenses | |
| Total Operating Expenses | |
| Operating Income | |
| EBITDA | |
| EBIT (Earnings Before Interest and Taxes) | |
| Net Profit | |
| Trademark | Date |
|---|---|
| ECONOPRED Pharmaceutical products for ophthalmological use | 02/22/2022 |
| TOBRASONE Pharmaceutical products for ophthalmological use | 02/22/2022 |
| XANGEN Irrigating solutions for eye use; ocular pharmaceuticals; ophthalmic and ophthalmological preparations; pharmaceutical products for ophthalmological use; solutions for lubrication and rewetting the eyes; eye drops; solutions for ocular hydration; solutions for reducing ocular inflammation and pain associated with ocular surgery and other pathologies; pharmaceutical preparations for ocular or intraocular surgery; solutions for reducing symptoms associated with conjunctivitis; pharmaceutical preparations for the prevention and treatment of eye disorders, diseases and conditions; solutions and preparations for treating pathologies of the eyelids and eyelid margins; pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists | 01/17/2020 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| XYMOGEN | Orlando, FL | 100 |
| AVANTI NUTRITIONAL LABORATORIES | Miami Lakes, FL | 37 |
| NUTRITION FORMULATORS | Miramar, FL | 36 |
| RTPR | Cabot, AR | 33 |
| INTEGRATED BOTANICS | Fort Worth, TX | 29 |
| COSMAX NBT USA | Garland, TX | 29 |
| CJB INDUSTRIES | Valdosta, GA | 28 |
| ALTERNATIVE LABORATORIES | Naples, FL | 28 |
| S&B PHARMA | Azusa, CA | 28 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| VETOQUINOL USA | Fort Worth, TX | 100 |
| CAPELLON | Fort Worth, TX | 63 |
| SOVEREIGN PHARMACEUTICALS | Fort Worth, TX | 49 |
| MONARCH PCM | Fort Worth, TX | 30 |
| EYEVANCE PHARMACEUTICALS | Fort Worth, TX | 28 |
| INTEGRATED BOTANICS | Fort Worth, TX | 27 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| ENERGY DOMAIN | Fort Worth, TX | 100 |
| WEATHERLY OPERATING | Fort Worth, TX | 0 |
| Company | Revenue ($ MM) |
|---|---|
![]() | |